Praxsyn Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXYN research report →
Companywww.praxsyn.com
Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts.
- CEO
- Sean Daly
- IPO
- 2010
- Employees
- 66
- HQ
- Las Vegas, IL, US
Price Chart
Valuation
- Market Cap
- $6.35K
- P/E
- -0.01
- P/S
- 0.08
- P/B
- 0.00
- EV/EBITDA
- -11.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 29.39%
- Op Margin
- -240.85%
- Net Margin
- -695.52%
- ROE
- -20.21%
- ROIC
- -4.71%
Growth & Income
- Revenue
- $81.38K · -90.06%
- Net Income
- $-566,000 · 83.81%
- EPS
- $-0.00 · 83.33%
- Op Income
- $-196,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.46
- Avg Volume
- 350.96K
Get TickerSpark's AI analysis on PXYN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PXYN Coverage
We haven't published any research on PXYN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PXYN Report →